PDF herunterladen
Endoscopy 2011; 43(6): 490-498
DOI: 10.1055/s-0030-1256357
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Algorithm for detection of small-bowel metastasis in malignant melanoma of the skin

J.  G.  Albert1 , 2 , M.  Fechner2 , E.  Fiedler3 , W.  Voderholzer4 , H.  Lochs4 , U.  Trefzer5 , W.  Sterry5 , S.  Vay6 , W.  Stremmel6 , A.  Enk7 , W.  C.  Marsch3 , W.  E.  Fleig8 , P.  Helmbold7
  • 1Department of Medicine I, Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
  • 2First Department of Medicine, Martin Luther University, Halle (Saale), Germany
  • 3Department of Dermatology, Martin Luther University, Halle (Saale), Germany
  • 4Department of Medicine, Charité Medical University, Berlin, Germany
  • 5Department of Dermatology, Charité Medical University, Berlin, Germany
  • 6Department of Medicine, University of Heidelberg, Heidelberg, Germany
  • 7Department of Dermatology, University of Heidelberg, Heidelberg, Germany
  • 8University of Leipzig Hospital and Clinics, Leipzig, Germany
Weitere Informationen

Publikationsverlauf

submitted 4 March 2010

accepted after revision 31 January 2011

Publikationsdatum:
26. Mai 2011 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Background and study aim: The aim of this study was to develop an algorithm to detect small-bowel metastasis (SBM) of melanoma by sequential laboratory parameters and pan-intestinal endoscopy (PIE) including video capsule endoscopy (VCE).

Patients and methods: A total of 390 melanoma patients (AJCC stage I/II/III/IV, 140/80/121/49) were screened for signs of intestinal blood loss (fecal occult blood test [FOBT] or overt bleeding) in an open, multicenter, prospective study, and those who were positive underwent PIE. Independent of the presence of intestinal bleeding, all stage IV patients were offered PIE. Follow-up was obtained in 357 patients (91.5 %) for a median of 16 months. We undertook to identify possible associations between SBM and clinical and laboratory data. Survival data were analyzed with regard to clinical and laboratory data and small-bowel findings.

Results: Intestinal blood loss was suspected in 49 of 390 patients (12.6 %), 38 of whom (77.6 %) agreed to undergo endoscopy. In 10 patients, SBM was detected by VCE (intention-to-diagnose, 20.4 %; AJCC III, n = 2; AJCC IV, n = 8). The SBM was resected in five patients. Total detection rates of SBM were 14 of 49 patients in stage IV (28.6 %, intention-to-diagnose), 2 of 121 in stage III (1.7 %), and 0 in stage I/II. In FOBT-positive patients, SBM detection rates were 72.7 %, 14.3 %, and 0 % in tumor stages IV, III, and I/II, respectively. Positive FOBT proved to be an independent negative prognostic factor for total survival in stage III and IV melanoma.

Conclusions: SBMs are frequent in advanced melanoma. In stage III patients, screening for intestinal blood loss by PIE may help to identify SBMs. In stage IV, indication for PIE should depend on the individual consequences of detecting SBM, but not on bleeding symptoms alone.

References

  • 1 Lasithiotakis K G, Leiter U, Gorkievicz R et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.  Cancer. 2006;  107 1331-1339
    CrossrefPubMedGoogle Scholar
  • 2 McCaul K A, Fritschi L, Baade P, Coory M. The incidence of second primary invasive melanoma in Queensland, 1982 – 2003.  Cancer Causes Control. 2008;  19 451-458
    CrossrefPubMedGoogle Scholar
  • 3 Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials.  Cancer. 2006;  107 (7 Suppl) 1645-1655
    CrossrefPubMedGoogle Scholar
  • 4 Backman H, Davidsson L. Metastases of malignant melanoma in the stomach and small intestine.  Acta Med Scand. 1965;  178 329-335
    PubMedGoogle Scholar
  • 5 Poteshan N L. Metastatic tumor to the small bowel. Three cases simulating primary malignant tumors.  Am J Roentgenol Radium Ther Nucl Med. 1967;  99 122-126
    PubMedGoogle Scholar
  • 6 Macbeth W A, Gwynne J F, Jamieson M G. Metastatic melanoma in the small bowel.  Aust N Z J Surg. 1969;  38 309-315
    CrossrefPubMedGoogle Scholar
  • 7 Richie R E, Reynolds V H, Sawyers J L. Tumor metastases to the small bowel from extra-abdominal sites.  South Med J. 1973;  66 1383-1387
    CrossrefPubMedGoogle Scholar
  • 8 Byrd B F, Morton C EI. Malignant melanoma metastatic to the gastrointestinal tract from an occult primary tumor.  South Med J. 1978;  71 1306-1308
    CrossrefPubMedGoogle Scholar
  • 9 Das Gupta T, Brasfield R. Metastatic melanoma of the gastrointestinal tract.  Arch Surg. 1964;  88 969-973
    CrossrefPubMedGoogle Scholar
  • 10 Patel J K, Didolkar M S, Pickren J W, Moore R H. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases.  Am J Surg. 1978;  135 807-810
    CrossrefPubMedGoogle Scholar
  • 11 Mosimann F, Fontolliet C, Genton A et al. Resection of metastases to the alimentary tract from malignant melanoma.  Int Surg. 1982;  67 257-260
    PubMedGoogle Scholar
  • 12 Lasithiotakis K G, Leiter U, Eigentler T et al. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001: which factors contributed?.  Cancer. 2007;  109 1174-1182
    CrossrefPubMedGoogle Scholar
  • 13 Ollila D W, Essner R, Wanek L A, Morton D L. Surgical resection for melanoma metastatic to the gastrointestinal tract.  Arch Surg. 1996;  131 975-980
    CrossrefPubMedGoogle Scholar
  • 14 Sharpless S M, Das Gupta T K. Surgery for metastatic melanoma.  Semin Surg Oncol. 1998;  14 311-318
    CrossrefPubMedGoogle Scholar
  • 15 Panagiotou I, Brountzos E N, Bafaloukos D et al. Malignant melanoma metastatic to the gastrointestinal tract.  Melanoma Res. 2002;  12 169-173
    CrossrefPubMedGoogle Scholar
  • 16 Essner R. Surgical treatment of malignant melanoma.  Surg Clin North Am. 2003;  83 109-156
    CrossrefPubMedGoogle Scholar
  • 17 Ollila D W, Caudle A S. Surgical management of distant metastases.  Surg Oncol Clin N Am. 2006;  15 385-398
    CrossrefPubMedGoogle Scholar
  • 18 Kadivar T F, Vanek V W, Krishnan E U. Primary malignant melanoma of the small bowel: a case study.  Am Surg. 1992;  58 418-422
    PubMedGoogle Scholar
  • 19 Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy.  Nature. 2000;  405 417
    PubMedGoogle Scholar
  • 20 Lens M, Bataille V, Krivokapic Z. Melanoma of the small intestine.  Lancet Oncol. 2009;  10 516-521
    CrossrefPubMedGoogle Scholar
  • 21 Albert J G, Gimm O, Stock K et al. Small-bowel endoscopy is crucial for diagnosis of melanoma metastases to the small bowel: a case of metachronous small bowel metastases and review of the literature.  Melanoma Res. 2007;  17 335-338
    CrossrefPubMedGoogle Scholar
  • 22 Reintgen D S, Thompson W, Garbutt J, Seigler H F. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract.  Surgery. 1984;  95 635-639
    PubMedGoogle Scholar
  • 23 Klaase J M, Kroon B B. Surgery for melanoma metastatic to the gastrointestinal tract.  Br J Surg. 1990;  77 60-61
    CrossrefPubMedGoogle Scholar
  • 24 Branum G D, Seigler H F. Role of surgical intervention in the management of intestinal metastases from malignant melanoma.  Am J Surg. 1991;  162 428-431
    CrossrefPubMedGoogle Scholar
  • 25 Ricaniadis N, Konstadoulakis M M, Walsh D, Karakousis C P. Gastrointestinal metastases from malignant melanoma.  Surg Oncol. 1995;  4 105-110
    CrossrefPubMedGoogle Scholar
  • 26 Krige J E, Nel P N, Hudson D A. Surgical treatment of metastatic melanoma of the small bowel.  Am Surg. 1996;  62 658-663
    PubMedGoogle Scholar
  • 27 Agrawal S, Yao T J, Coit D G. Surgery for melanoma metastatic to the gastrointestinal tract.  Ann Surg Oncol. 1999;  6 336-344
    CrossrefPubMedGoogle Scholar
  • 28 Gutman H, Hess K R, Kokotsakis J A et al. Surgery for abdominal metastases of cutaneous melanoma.  World J Surg. 2001;  25 750-758
    CrossrefPubMedGoogle Scholar
  • 29 Sanki A, Scolyer R A, Thompson J F. Surgery for melanoma metastases of the gastrointestinal tract: indications and results.  Eur J Surg Oncol. 2009;  35 313-319
    CrossrefPubMedGoogle Scholar
  • 30 Geboes K, De Jaeger E, Rutgeerts P, Vantrappen G. Symptomatic gastrointestinal metastases from malignant melanoma. A clinical study.  J Clin Gastroenterol. 1988;  10 64-70
    CrossrefPubMedGoogle Scholar
  • 31 Neu B, Ell C, May A et al. Capsule endoscopy versus standard tests in influencing management of obscure digestive bleeding: results from a German multicenter trial.  Am J Gastroenterol. 2005;  100 1736-1742
    CrossrefPubMedGoogle Scholar
  • 32 Triester S L, Leighton J A, Leontiadis G I et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding.  Am J Gastroenterol. 2005;  100 2407-2418
    CrossrefPubMedGoogle Scholar
  • 33 Albert J G, Martiny F, Krummenerl A et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis.  Gut. 2005;  54 1721-1727
    CrossrefPubMedGoogle Scholar
  • 34 Cobrin G M, Pittman R H, Lewis B S. Increased diagnostic yield of small bowel tumors with capsule endoscopy.  Cancer. 2006;  107 22-27
    CrossrefPubMedGoogle Scholar
  • 35 Bailey A A, Debinski H S, Appleyard M N et al. Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience.  Am J Gastroenterol. 2006;  101 2237-2243
    CrossrefPubMedGoogle Scholar
  • 36 Prakoso E, Selby W S. Capsule endoscopy in patients with malignant melanoma.  Am J Gastroenterol. 2007;  102 1204-1208
    CrossrefPubMedGoogle Scholar
  • 37 Balch C M, Buzaid A C, Soong S J et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.  J Clin Oncol. 2001;  19 3635-3648
    PubMedGoogle Scholar
  • 38 Verdecchia A, Francisci S, Brenner H et al. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data.  Lancet Oncol. 2007;  8 784-796
    CrossrefPubMedGoogle Scholar
  • 39 Ries L, Harkins D, Krapcho M et al. SEER Cancer Statistics Review, 1975–2004, National Cancer Institute. Bethesda. 2007 http://seer.cancer.gov/csr/1975_2004/ based on November 2006 SEER data submission, posted to the SEER web site 2007. Last accessed 26 November 2009
    Google Scholar
  • 40 Balch C M, Soong S J, Gershenwald J E et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.  J Clin Oncol. 2001;  19 3622-3634
    PubMedGoogle Scholar
  • 41 de la Monte S M, Moore G W, Hutchins G M. Patterned distribution of metastases from malignant melanoma in humans.  Cancer Res. 1983;  43 3427-3433
    PubMedGoogle Scholar
  • 42 Bender G N, Maglinte D D, McLarney J H et al. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance.  Am J Gastroenterol. 2001;  96 2392-2400
    PubMedGoogle Scholar
  • 43 Galmiche J P, Coron E, Sacher-Huvelin S. Recent developments in capsule endoscopy.  Gut. 2008;  57 695-703
    CrossrefPubMedGoogle Scholar
  • 44 Rosenberg S A, Yang J C, Topalian S L et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.  JAMA. 1994;  271 907-913
    CrossrefPubMedGoogle Scholar
  • 45 Middleton M, Hauschild A, Thomson D et al. Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-alpha2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.  Ann Oncol. 2007;  18 1691-1697
    CrossrefPubMedGoogle Scholar
  • 46 Hill J H, Krementz E T, Hill H Z. Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A).  Cancer. 1984;  53 1299-1305
    CrossrefPubMedGoogle Scholar
  • 47 Elsayed A M, Albahra M, Nzeako U C, Sobin L H. Malignant melanomas in the small intestine: a study of 103 patients.  Am J Gastroenterol. 1996;  91 1001-1006
    PubMedGoogle Scholar
  • 48 Ollila D W. Complete metastasectomy in patients with stage IV metastatic melanoma.  Lancet Oncol. 2006;  7 919-924
    CrossrefPubMedGoogle Scholar
  • 49 Richmond A. CCR9 homes metastatic melanoma cells to the small bowel.  Clin Cancer Res. 2008;  14 621-623
    CrossrefPubMedGoogle Scholar
  • 50 Amersi F F, Terando A M, Goto Y et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.  Clin Cancer Res. 2008;  14 638-645
    CrossrefPubMedGoogle Scholar

J. G. AlbertMD 

Department of Medicine I
Johann Wolfgang Goethe University Frankfurt

D- 60590 Frankfurt/Main
Germany

Fax: +49-69-63016448

eMail: joerg.albert@kgu.de